Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0155339 (
Brown
)
12,436
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The susceptibilities of different strains of inbred rats to infection with the human T-cell leukemia virus (HTLV-I) after inoculation of human HTLV-I producer cell lines were compared. The Fisher F344 and
Brown
Norway strains developed the highest antibody response to HTLV-I, while the Lewis and BB strains were low responders. Antibodies against the HTLV-I gag proteins, and env gp21 but not env gp46, were detected in Western blots with sera from HTLV-I-infected Fischer F344 and
Brown
Norway rats. These sera were inactive in an in vitro syncytium-formation inhibition test. The HTLV-I provirus was detected by polymerase chain reaction in all Fischer F344, and some Lewis and
Brown
Norway rats, but not in the BB, which lack CD8+ T lymphocytes. The most frequent locations of the HTLV-I provirus in the Fischer F344, Lewis and
Brown
Norway rats at 12 weeks after infection were the peripheral blood mononuclear cells (PBMC) and spinal cord. In a second experiment in
Brown
Norway rats, the provirus was again detected in the PBMC of rats at 12 weeks, but not at 22 weeks, and among the other organs tested at 22 weeks the sympathetic nerve ganglia were positive. It is concluded that
HTLV-I infection
occurs in adult rats, but is suppressed with time.
...
PMID:Infection of rats with human T-cell leukemia virus type-I: susceptibility of inbred strains, antibody response and provirus location. 805 Aug 26
Three aspects of the rat model of
HTLV-I
/II infection were investigated. (i) The efficacy of
HTLV-I
-transformed rat cell lines in infecting different strains of rats: WKY and Lewis
HTLV-I
-transformed cell lines were injected into adult WKY, Lewis and
Brown
Norway rats, representing syngeneic and allogeneic combinations. The
HTLV-I
provirus was not detected in peripheral-blood mononuclear cells (PBMC) from these rats 18 weeks after inoculation, showing that
HTLV-I
-transformed rat cells are not suitable for virus challenge in vaccination experiments. Rats inoculated with Lewis
HTLV-I
-transformed cells produced an antibody response to
HTLV-I
, which was higher in allogeneic (WKY and
Brown
Norway) than in syngeneic rats. (ii) The susceptibility of rats to HTLV-II infection: After human HTLV-II-producing cells (MO) were injected into adult WKY rats, the HTLV-II provirus was detected in PBMC 12 weeks later. Sequencing of a portion of this provirus confirmed its identity with the HTLV-II from MO cells. (iii) The role of MHC haplotype in susceptibility to neurological disease in rats inoculated as newborns with
HTLV-I
: The hypothesis that the RT-Ik haplotype confers susceptibility was tested by inoculating newborn OKA (RT-Ik), WKY (RT-Il), Lewis (RT-Il) and Fischer 344 (RT-I lvl) rats with human
HTLV-I
-producing cells (MT-2). Eighteen months later, only the WKY rats showed histological abnormality of the spinal cord, without clinical paralysis. Fischer 344 rats developed cutaneous tumors and OKA rats mammary tumors. The
HTLV-I
provirus was not detected in these tumors.
...
PMID:Role of the genetic background of rats in infection by HTLV-I and HTLV-II and in the development of associated diseases. 933 20